184 related articles for article (PubMed ID: 851483)
21. Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase.
Bock PE; Day DE; Verhamme IM; Bernardo MM; Olson ST; Shore JD
J Biol Chem; 1996 Jan; 271(2):1072-80. PubMed ID: 8557633
[TBL] [Abstract][Full Text] [Related]
22. Interaction of staphylokinase with different molecular forms of plasminogen.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
[TBL] [Abstract][Full Text] [Related]
23. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins.
Summaria L; Spitz F; Arzadon L; Boreisha IG; Robbins KC
J Biol Chem; 1976 Jun; 251(12):3693-9. PubMed ID: 132440
[TBL] [Abstract][Full Text] [Related]
25. A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.
Rajagopalan S; Gonias SL; Pizzo SV
J Clin Invest; 1985 Feb; 75(2):413-9. PubMed ID: 3156148
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of active center formation in dog plasminogin by streptokinase and activity of a modified streptokinase.
Reddy KN
J Biol Chem; 1976 Nov; 251(21):6624-9. PubMed ID: 977590
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of the urokinase-catalyzed activation of human plasminogen.
Violand BN; Castellino FJ
J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the interaction between plasminogen and staphylokinase.
Lijnen HR; De Cock F; Van Hoef B; Schlott B; Collen D
Eur J Biochem; 1994 Aug; 224(1):143-9. PubMed ID: 8076635
[TBL] [Abstract][Full Text] [Related]
29. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
Cassels R; Fears R; Smith RA
Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
[TBL] [Abstract][Full Text] [Related]
30. Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex.
Markus G; Evers JL; Hobika GH
J Biol Chem; 1976 Nov; 251(21):6495-504. PubMed ID: 135763
[TBL] [Abstract][Full Text] [Related]
31. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
Ryan TJ; Keegan MC
Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
[TBL] [Abstract][Full Text] [Related]
32. Structural domains of streptokinase involved in the interaction with plasminogen.
Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of a bacterial plasminogen activator intermediate between streptokinase and staphylokinase.
Sazonova IY; Houng AK; Chowdhry SA; Robinson BR; Hedstrom L; Reed GL
J Biol Chem; 2001 Apr; 276(16):12609-13. PubMed ID: 11278483
[TBL] [Abstract][Full Text] [Related]
34. Purification and some properties of the Glu- and Lys-human plasmin heavy chains.
Gonzalez-Gronow M; Violand BN; Castellino FJ
J Biol Chem; 1977 Apr; 252(7):2175-7. PubMed ID: 139407
[TBL] [Abstract][Full Text] [Related]
35. Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase.
Boxrud PD; Verhamme IM; Bock PE
J Biol Chem; 2004 Aug; 279(35):36633-41. PubMed ID: 15215240
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
37. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
38. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
39. An anti-plasminogen antibody preparation that inhibits the activation of human plasminogen but enhances the activator activity of the B-chain-streptokinase complex.
Summaria L; Pavlovic B; Sandesara J
Thromb Res; 1989 Apr; 54(1):1-15. PubMed ID: 2727955
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
Ellis V; Scully MF; Kakkar VV
J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
